Cargando…

Influence of Thyroid-stimulating Hormone Suppression Therapy on Bone Mineral Density in Patients with Differentiated Thyroid Cancer: A Meta-analysis

BACKGROUND: The effects of subclinical hyperthyroidism on bone mineral density (BMD) induced by thyroid-stimulating hormone (TSH) suppression therapy in patients with differentiated thyroid cancer (DTC) remains unclear. We conducted a meta-analysis to determine the influence of TSH suppression thera...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yoon, Byung-Ho, Lee, Youjin, Oh, Hyun Jin, Kim, Sung Han, Lee, Young-Kyun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society for Bone and Mineral Research 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6416150/ https://www.ncbi.nlm.nih.gov/pubmed/30899725 http://dx.doi.org/10.11005/jbm.2019.26.1.51

Ejemplares similares

Risk of Osteoporotic Fractures after Thyroid-stimulating Hormone Suppression Therapy in Patients with Thyroid Cancer
por: Lee, Youjin, et al.
Publicado: (2019)

Measurements of Bone Health after Thyroid-Stimulating Suppression Therapy in Postmenopausal Women with Differentiated Thyroid Carcinoma: Bone Mineral Density versus the Trabecular Bone Score
por: Chung, Chae Won, et al.
Publicado: (2021)

The risk between thyrotropin suppression and bone mineral density in differentiated thyroid cancer
por: Zou, Yang, et al.
Publicado: (2022)

Effects of thyroid-stimulating hormone suppression after thyroidectomy for thyroid cancer on bone mineral density in postmenopausal women: a systematic review and meta-analysis
por: Kwak, Donghee, et al.
Publicado: (2021)

Change of Bone Mineral Density and Biochemical Markers of Bone Turnover in Patients on Suppressive Levothyroxine Therapy for Differentiated Thyroid Carcinoma
por: Kim, Chei Won, et al.
Publicado: (2015)

Bone mineral density and bone turnover markers in patients on long-term suppressive levothyroxine therapy for differentiated thyroid cancer
por: Lee, Mi Young, et al.
Publicado: (2014)

Effects of thyrotropin suppression on lumbar bone mineral density in postmenopausal women with differentiated thyroid carcinoma
por: Zhang, Pei, et al.
Publicado: (2018)

Effect of Suppressive Levothyroxine Therapy on Bone Mineral Density in Young Patients with Differentiated Thyroid Carcinoma
por: Zanella, André Borsatto, et al.
Publicado: (2022)

Thyroid stimulating hormone suppression time on cardiac function of patients with differentiated thyroid carcinoma
por: Wang, Ruihua, et al.
Publicado: (2018)

Roxadustat and thyroid-stimulating hormone suppression
por: Tokuyama, Atsuyuki, et al.
Publicado: (2021)

Association between Sensitivity to Thyroid Hormone Indices and Bone Mineral Density in US Males
por: Chen, Shuai, et al.
Publicado: (2022)

A systematic review of the relationship between normal range of serum thyroid-stimulating hormone and bone mineral density in the postmenopausal women
por: Zhu, Xiaoli, et al.
Publicado: (2023)

Lack of Influence of Thyroid Hormone on Bone Mineral Density and Body Composition in Healthy Euthyroid Women
por: Zantut-Wittmann, Denise Engelbrecht, et al.
Publicado: (2020)

Effect of withdrawal of thyroid hormones versus administration of recombinant human thyroid-stimulating hormone on renal function in thyroid cancer patients
por: An, Young-Sil, et al.
Publicado: (2023)

The Effect of ThyroidߚStimulating Hormone on Stage of Differentiated Thyroid Carcinoma
por: Soleimanisardoo, Laya, et al.
Publicado: (2021)

Thyroid function and bone mineral density among Indian subjects
por: Marwaha, Raman K., et al.
Publicado: (2012)

Bone Turnover in Relation to Thyroid-Stimulating Hormone in Hypothyroid Patients on Thyroid Hormone Substitution Therapy
por: Bjerkreim, Betty Ann, et al.
Publicado: (2022)

Effect of Thyroid-Stimulating Hormone Suppression on Muscle Function After Total Thyroidectomy in Patients With Thyroid Cancer
por: Lee, Jun Choul, et al.
Publicado: (2021)

Regulation of Inhibitors of Differentiation Family Proteins by Thyroid-Stimulating Hormone in FRTL-5 Thyroid Cells
por: Jo, Young Suk, et al.
Publicado: (2008)

Thyroid hormones and minerals in immunocorrection of disorders in autoimmune thyroid diseases
por: Kravchenko, Viktor, et al.
Publicado: (2023)

Weight Changes in Patients with Differentiated Thyroid Carcinoma during Postoperative Long-Term Follow-up under Thyroid Stimulating Hormone Suppression
por: Sohn, Seo Young, et al.
Publicado: (2015)

Goitrogenic Anions, Thyroid-Stimulating Hormone, and Thyroid Hormone in Infants
por: Cao, Yang, et al.
Publicado: (2010)

Relationship between Vitamin D, Parathyroid Hormone, and Bone Mineral Density in Elderly Koreans
por: Kim, Guilsun, et al.
Publicado: (2012)

Naming difficulties after thyroid stimulating hormone suppression therapy in patients with differentiated thyroid carcinoma: a prospective cohort study
por: Jin, Shan, et al.
Publicado: (2019)

Environmental Factors Affecting Thyroid-Stimulating Hormone and Thyroid Hormone Levels
por: Babić Leko, Mirjana, et al.
Publicado: (2021)

Postoperative Thyroid-Stimulating Hormone Levels Did Not Affect Recurrence after Thyroid Lobectomy in Patients with Papillary Thyroid Cancer
por: Lee, Myung-Chul, et al.
Publicado: (2019)

Changes in bone mineral density and trabecular bone score in Graves' disease patients after anti-thyroid therapy
por: Ock, So Young, et al.
Publicado: (2016)

Economic Evaluation of Recombinant Human Thyroid Stimulating Hormone Stimulation vs. Thyroid Hormone Withdrawal Prior to Radioiodine Ablation for Thyroid Cancer: The Korean Perspective
por: Sohn, Seo Young, et al.
Publicado: (2015)

Thyroid Stimulating Hormone Receptor
por: Tuncel, Murat
Publicado: (2017)

Recombinant Human Thyroid Stimulating Hormone versus Thyroid Hormone Withdrawal for Radioactive Iodine Treatment of Differentiated Thyroid Cancer with Nodal Metastatic Disease
por: Wolfson, Robert M., et al.
Publicado: (2016)

Elevated thyroid stimulating hormone levels are associated with metabolic syndrome in euthyroid young women
por: Oh, Jee-Young, et al.
Publicado: (2013)

Thyroid disorders and bone mineral metabolism
por: Dhanwal, Dinesh Kumar
Publicado: (2011)

Is Very High Thyroid Stimulating Hormone Level Required in Differentiated Thyroid Cancer for Ablation Success?
por: Hasbek, Zekiye, et al.
Publicado: (2016)

Health Anxiety and Its Relationship to Thyroid-Hormone-Suppression Therapy in Patients with Differentiated Thyroid Cancer
por: Zoltek, Maximilian, et al.
Publicado: (2022)

Association between Thyroid-Stimulating Hormone Level after Total Thyroidectomy and Hypercholesterolemia in Female Patients with Differentiated Thyroid Cancer: A Retrospective Study
por: Lee, Young Ki, et al.
Publicado: (2019)

Relationship between thyroid stimulating hormone and night shift work
por: Moon, So-Hyun, et al.
Publicado: (2016)

Correlation of thyroid hormone measurements with thyroid stimulating hormone stimulation test results in radioiodine‐treated cats
por: Wakeling, Jennifer, et al.
Publicado: (2020)

Pars Distalis and Pars Tuberalis Thyroid-Stimulating Hormones and Their Roles in Macro-Thyroid-Stimulating Hormone Formation
por: Fröhlich, Eleonore, et al.
Publicado: (2023)

Bone Mineral Density in Prediabetic Men
por: Lee, Ju Hee, et al.
Publicado: (2010)

Spindle epithelial tumor with thymus-like differentiation of the thyroid in a 70-year-old man
por: Lee, Sunhye, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_e344doqa9utr6qbkpd61gn1r18